亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Wnt1 for the Treatment of Peripheral Vascular Disease and the Repair of Heart

技術優勢
This is the first time that the role of Wnt1 in enhancing cardiac repair after acute cardiac injury has been described and demonstratedIt has been demonstrated that Wnt1 can also enhance function of human endothelial progenitors
技術應用
Can be used as a novel therapy for cardiac repair after acute cardiac injury Can be used as a therapeutic agent to increase blood flow to ischemic extremities Can be used to enhance the function of endothelial progenitor cells prior to cell based therapy in clinical trials
詳細技術說明
Dr. Arjun Deb and colleagues in the Department of Medicine have demonstrated that Wnt1 is an agent critical for cardiac repair. After acute cardiac injury, Wnt is expressed in the epicardium of the heart and cardiac fibroblasts, and orchestrates a critical early repair response. Interruption of downstream Wnt signaling leads to the development of heart failure and death within a few days of injury. In addition, the researchers discovered that Wnt1 can also enhance human endothelial progenitor function.
*Abstract
UCLA researchers in the Department of Medicine have developed a novel therapeutic agent for cardiac repair after acute cardiac injury.
*Applications
  • Can be used as a novel therapy for cardiac repair after acute cardiac injury 
  • Can be used as a therapeutic agent to increase blood flow to ischemic extremities 
  • Can be used to enhance the function of endothelial progenitor cells prior to cell based therapy in clinical trials
*IP Issue Date
Nov 17, 2015
*Principal Investigation

Name: Arjun Deb

Department:

申請號碼
9186388
其他

State Of Development

Researchers have experimentally demonstrated the physiological role and therapeutic effect of Wnt1 in the treatment of cardiovascular disease.

Background

Heart disease is a leading cause of mortality and morbidity and an emerging public health problem in the developing world. The inability of the mammalian heart to regenerate cardiac muscles after acute myocardial injury remains a fundamental biological problem to the therapy of heart disease. Therefore, there is a clear need for novel therapeutic strategies.

Related Materials

Duan, Jinzhu, et al. "Wnt1/beta-catenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair." The EMBO journal 31.2 (2012): 429-442.


Additional Technologies by these Inventors


Tech ID/UC Case

24785/2013-782-0


Related Cases

2013-782-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備